0
Your inquiries
Total:
Catalog of medicines India
Help
+91(994)0472902
Sales department
+91(994)0472902
English Support
If you have any questions when making a request, please contact the specified contacts.

Hepatitis C

 Hepatitis C is a viral pathology that is transmitted mainly through the blood and poses a serious danger to human health. The liver suffers the most from hepatitis C. The peculiarity of this disease is its asymptomatic course: people often do not suspect that they are sick.

Until recently, hepatitis C was treated with ribavirin and interferon. These drugs were not always effective and caused various adverse reactions. The situation changed with the invention of new antiviral drugs.

To date, the most effective treatment is considered to be with the use of two drugs - sofosbuvir and daclatasvir. According to the current EASL guidelines, these agents are prescribed for all genotypes of the virus. More than 23,000 patients from Russia who took these drugs were convinced of their effectiveness.

Properties of drugs

Sofosbuvir is an antiviral drug that has a direct effect on the virus. It is the main component in the treatment of adult patients with chronic hepatitis C. The peculiarity of sofosbuvir is that it acts only on the virus and blocks its reproduction in the body. The drug is used in combination with daclatasvir, ledipasvir, simeprevir, ribavirin and other medicines.

Daclatasvir inhibits the protein compounds of the NS5A virus and prevents the spread of infection in the body. As a result, it is possible to block the infection of healthy cells. Daclatasvir is not intended for monotherapy. It is included in complex treatment regimens and is used in conjunction with other antiviral drugs: ribavirin, asunaprevir, sofosbuvir, peginterferon, etc.

Benefits of Daclatasvir and Sofosbuvir

Numerous patient reviews indicate the high efficacy of the combination of daclatasvir and sofosbuvir. In addition, these drugs have virtually no adverse reactions. Complex therapy with the use of these medicines allows the patient to lead a normal life and does not affect the blood composition.

In addition, sofosbuvir and daclatasvir have the following benefits:

  • A small number of contraindications: the main limitation is associated with intolerance to the components of the drugs.
  • Good tolerance: negative reactions are rare.
  • High efficiency: in most cases, patients are completely cured.
  • Fast result: the effect is noticeable already after a few weeks from the start of treatment.

Indian generics for hepatitis C

Original drugs have a very high price, which is why most patients cannot buy them.

The emergence of generics from India has given people of any income level a chance to recover. Generic is an analogue, in composition and effectiveness, identical to the original drug. However, the cost of the analogue is much lower than the original.

The production of modern medicines is closely monitored by drug developers. In addition, regulatory authorities check the compliance of the generic with current quality and safety standards.

Before buying medicines, you need to consult your doctor. Only a specialist will be able to correctly determine the dosage and duration of treatment.

 
Define your treatment regimen using the table:

Virus genotype

Interferon therapy

Cirrhosis of the liver

Sofosbuvir Daklatasvir

Sofosbuvir Ledipasvir

Sofosbuvir Velpatasvir

Grazoprevir Elbasvir

Glecaprevir Pibrentasvir

Sofosbuvir Velpatasvir Voxilaprevir

Genotype 1

Not

Yes

24 weeks

24 weeks

24 weeks

-

12 weeks

12 weeks

Not

12 weeks

12 weeks

12 weeks

12 weeks

8 weeks

8 weeks

Yes

 

24 weeks

24 weeks

24 weeks

-

-

-

Genotype 2

Not

Yes

24 weeks

Not effective

24 weeks

Not effective

12 weeks

12 weeks

Not

12 weeks

12 weeks

8 weeks

8 weeks

Yes

 

24 weeks

24 weeks

-

-

Genotype 3

Not

Yes

24 weeks

Not effective

24 weeks

-

12 weeks

8 weeks

Not

12 weeks

12 weeks

12 weeks (in conjunction with sofosbuvir)

8 weeks

8 weeks

Yes

 

24 weeks

24 weeks

-

-

-

Genotype 4

Not

Yes

24 weeks

24 weeks

24 weeks

-

12 weeks

12 weeks

Not

12 weeks

12 weeks

12 weeks

12 weeks

8 weeks

8 weeks

Yes

 

24 weeks

24 weeks

24 weeks

-

-

-

Genotype 5-6

Not

Yes

24 weeks

24 weeks

24 weeks

Not effective

12 weeks

12 weeks

Not

12 weeks

12 weeks

12 weeks

8 weeks

8 weeks

Yes

 

24 weeks

24 weeks

24 weeks

-

-

Dacihep
Dacihep (Daclatasvir)
In stock
Active substance: Daclatasvir
40 $
Dacikast
Dacikast (Daclatasvir )
In stock
Active substance: Daclatasvir
40 $
Daclacure
Daclacure (Daclatasvir)
In stock
Active substance: Daclatasvir
40 $
Daclahep
Daclahep (Daclatasvir)
In stock
Active substance: Daclatasvir
40 $
Dalsiclear
Dalsiclear (Daclatasvir)
In stock
Active substance: Daclatasvir
40 $
Hepcdac
Hepcdac (Daclatasvir)
In stock
Active substance: Daclatasvir
40 $
Hepcfix
Hepcfix (Daclatasvir)
In stock
Active substance: Daclatasvir
40 $
Hepcinat
Hepcinat (Sofosbuvir)
In stock
Active substance: Sofosbuvir
80 $
Hepcinat LP
Hepcinat LP (Sofosbuvir & Ledipasvir)
In stock
Active substance: Sofosbuvir & Ledipasvir
165 $
Hepcvel Hepcvel
Hepcvel (Sofosbuvir & Velpatasvir)
In stock
Active substance: Sofosbuvir & Velpatasvir
525 $
Hepcvir
Hepcvir (Sofosbuvir)
In stock
Active substance: Sofosbuvir
65 $
Hepcvir L Hepcvir L Hepcvir L
Hepcvir L (Sofosbuvir Ledipasvir)
In stock
Active substance: Sofosbuvir Ledipasvir
145 $
Heptos 200mg
Heptos 200mg (Ribavirin)
In stock
Active substance: Ribavirin
40 $
Ledifos
Ledifos (Sofosbuvir & Ledipasvir)
In stock
Active substance: Sofosbuvir & Ledipasvir
105 $
Ledihep
Ledihep (Sofosbuvir & Ledipasvir)
In stock
Active substance: Sofosbuvir & Ledipasvir
105 $
Ledikast
Ledikast (Sofosbuvir & Ledipasvir)
In stock
Active substance: Sofosbuvir & Ledipasvir
95 $
Ledviclear
Ledviclear (Sofosbuvir Ledipasvir)
In stock
Active substance: Sofosbuvir Ledipasvir
105 $
Mydekla
Mydekla (Daclatasvir)
In stock
Active substance: Daclatasvir
40 $
Myhep
Myhep (Sofosbuvir)
In stock
Active substance: Sofosbuvir
65 $
Myhep All Myhep All Myhep All
Myhep All (Sofosbuvir & Velpatasvir)
In stock
Active substance: Sofosbuvir & Velpatasvir
499 $
Discount!
Myhep DVIR
Myhep DVIR (Sofosbuvir & Daclatasvir)
In stock
Active substance: Sofosbuvir & Daclatasvir
389 $
399 $
-2%
10 $
Myhep LVIR
Myhep LVIR (Sofosbuvir & Ledipasvir)
In stock
Active substance: Sofosbuvir & Ledipasvir
105 $
Natdac
Natdac (Daclatasvir)
In stock
Active substance: Daclatasvir
45 $
Qurdac
Qurdac (Daclatasvir)
Check the price with the manager
Active substance: Daclatasvir
 
 
 
 
We use cookies to make the site better for you! Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments.